MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Debt to Asset Ratio
17.23%
Unit: Dollar
Assets Breakdown
Cash and cash equivalents
Inventory
Intangible assets
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated earnings (deficit)
Due to related parties-Related P...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2025-09-30
Cash and cash equivalents
1,139,423
Accounts receivable, net
63,212
Inventory
757,500
Prepaid expense
34,864
Overpayment to related parties
0
Total current assets
1,994,999
Intangible assets
72,101
Total assets
2,067,100
Accounts payable
10,165
Due to related parties-Related Party
228,298
Accrued expenses
6,686
Deferred revenue
110,991
Total current liabilities
356,140
Series a convertible preferred stock, 1,000,000 designated, 140,000 shares issued and outstanding at september 30, 2025 and december 31, 2024
14
Common stock 0.0001 par value, 250,000,000 shares authorized 10,979,055 shares issued and outstanding at september 30, 2025 and december 31, 2024
1,098
Additional paid-in capital
1,175,211
Accumulated earnings (deficit)
534,637
Total stockholders' equity (deficit)
1,710,960
Total liabilities and stockholders' equity (deficit)
2,067,100
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$1,139,423
Inventory
$757,500
Accounts receivable, net
$63,212
Prepaid expense
$34,864
Total current assets
$1,994,999
Intangible assets
$72,101
Total assets
$2,067,100
Total liabilities and
stockholders' equity...
$2,067,100
Total stockholders'
equity (deficit)
$1,710,960
Total current
liabilities
$356,140
Additional paid-in capital
$1,175,211
Accumulated earnings
(deficit)
$534,637
Common stock 0.0001 par
value, 250,000,000...
$1,098
Series a convertible
preferred stock,...
$14
Due to related
parties-Related Party
$228,298
Deferred revenue
$110,991
Accounts payable
$10,165
Accrued expenses
$6,686
Buy us a coffee
BioScience Health Innovations, Inc. (BHICD)
BioScience Health Innovations, Inc. (BHICD)